Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9-19years

Journal of Cystic Fibrosis

Volumn 12, Issue 6, 2013, Pages 746-753

  Shoff, Suzanne M ^a,b,c   Tluczek, Audrey ^a,b,c   Laxova, Anita ^a,b,c   Farrell, Philip M ^a,b,c   Lai, HuiChuan J ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON SCHOOL OF NURSING   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cystic fibrosis; Nutrition; Quality of life

Indexed keywords

ADULT; ARTICLE; BODY HEIGHT; BODY IMAGE; BODY MASS; BODY WEIGHT; CHILD; CYSTIC FIBROSIS; CYSTIC FIBROSIS QUESTIONNAIRE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEWBORN SCREENING; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PHENOTYPE; QUALITY OF LIFE; SCHOOL CHILD; SHORT STATURE; SOCIAL INTERACTION; UNDERWEIGHT; UNITED STATES;

CYSTIC FIBROSIS; NUTRITION; QUALITY OF LIFE;

ADOLESCENT; CHILD; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; NUTRITIONAL STATUS; PANCREAS; QUALITY OF LIFE; YOUNG ADULT;

EID: 84888018319     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.01.006     Document Type: Article

References (28)

1. Borowitz D., Robinson K.A., Rosenfeld R., Davis S.D., Sabadosa K.A., Spear L.S., et al. Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009, 155:S73-S93.
2. Stallings V.A., Stark L.J., Robinson K.A., Feranchak A.P., Quinton H.B. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008, 108:832-839.
3. Milla C.E. Association of nutritional status and pulmonary function in children with cystic fibrosis. Curr Opin Pulm Med 2004, 10:505-509.
4. Zemel B.S., Jawad A.F., FitzSimmons S., Stallings V. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 2000, 137:374-380.
5. Tluczek A., Becker T., Laxova A., et al. Relationships among health-related quality of life, pulmonary health and newborn screening for cystic fibrosis. Chest 2011, 140:170-177.
6. Gee L., Abbott J., Hart A., Conway S.P., Etherington C., Webb A.K. Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros 2005, 4:59-66.
7. Gee L., Abbott J., Conway S.P., Etherington C., Webb A.K. Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. J Cyst Fibros 2003, 2:206-213.
8. Sawicki G.S., Sellers D.E., Robinson W.M. Associations between illness perceptions and health-related quality of life in adults with cystic fibrosis. J Psychosom Res 2011, 70:161-167.
9. Sawicki G.S., Rasouliyan L., McMullen A.H., Wagener J.S., McColley S.A., Pasta D.J., et al. Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis. Pediatr Pulmonol 2011, 46:36-44.
10. Simon S.L., Duncan C.L., Horky S.C., Nick T.G., Castro M.M., Riekert K.A. Body satisfaction, nutritional adherence, and quality of life in youth with cystic fibrosis. Pediatr Pulmonol 2011, 46:1085-1092.
11. Wolter J., Seeney S., Bell S., Bowler S., Masel P., McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomized tiral. Thorax 2002, 57:212-216.
12. Saiman L., Marshall B.C., Mayer-Hamblett N., Burns J.L., Quittner A.L., Cibene D.A., et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003, 290:1749-1756.
13. Elkins M.R., Robinson M., Rose B.R., et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006, 354:229-240.
14. Donaldson S.H., Bennett W.D., Zeman K.L., Knowles M.R., Tarran R., Boucher R.C. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006, 354:241-250.
15. Accurso F.J., Rowe S.M., Clancy J.P., Boyle M.P., Dunitz J.M., Durie P.R., et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010, 363:1991-2003.
16. Modi A.C., Lim C.S., Driscoll K.A., Piazza-Waggoner C., Quittner A.L., Wooldridge J. Changes in pediatric health-related quality of life in cystic fibrosis after IV antibiotic treatment for pulmonary exacerbations. J Clin Psychol Med Settings 2010, 17:49-55.
17. Oermann C.M., Retsch-Bogart G.Z., Quittner A.L., Gibson R.L., McCoy K.S., Montgomery A.B., et al. An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Pediatr Pulmonol 2010, 45:1121-1134.
18. Fost N.C., Farrell P.M. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clin Res 1989, 37:495-500.
19. Farrell P.M., Kosorok M.R., Laxova A., Shen G., Koscik R.E., Bruns W.T., et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med 1997, 337:963-969.
20. Quittner A.L., Buu A., Messer M.A., Modi A.C., Watrous M. Development and validation of the Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005, 128:2347-2354.
21. Quittner A.L., Buu A., Watrous M., Davis M.A. The cystic fibrosis questionnaire: user's manual 2000, Cystic Fibrosis Foundation, Washington, DC.
22. Modi A.C., Quittner A.L. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003, 28:535-545.
23. Kuczmarski R.J., Ogden C.L., Guo S.S., Gummer-Strawn L.M., Flegal K., Mei Z., et al. CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 2000, 11(246):2002.
24. Lai H.J., Shoff S.M. Classification of malnutrition in cystic fibrosis: implications for evaluating and benchmarking clinical practice performance. Am J Clin Nutr 2008, 88:161-166.
25. Borowitz D., Baker R.D., Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002, 35:246-259.
26. Quittner A.L., Sawicki G.X., McMullen A., Rasouliyan L., Pasta D.J., Yegin A., et al. Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample. Qual Life Res 2012, [published online January 13].
27. Abbott J., Hart A., Havermans T., Matossian A., Goldbeck L., Barreto C., et al. Measuring health-related quality of life in clinical trials in cystic fibrosis. J Cyst Fibros 2011, 10(Suppl. 2):S82-S85.
28. Quittner A.L., Modi A.C., Wainwright C., Otto K., Kirihara J., Montgomery A.B. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009, 135:1610-1618.